A Phase 1b Study: Treatment of Refractory Pancreatic Adenocarcinoma and Advanced Soft Tissue or Bone Sarcomas Using Decitabine Combined With Gemcitabine
Phase of Trial: Phase I
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Decitabine (Primary) ; Gemcitabine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer; Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 23 Jun 2017 Planned number of patients changed from 36 to 42.
- 01 Feb 2017 Status changed from not yet recruiting to recruiting.
- 11 Nov 2016 New trial record